CME Accreditation

Earn up to 21 CME Credits in 2022

To Claim Your 2022 CME Certificate

If you are a CSF 2022 meeting participant, please use the link below to complete the required survey and to claim your certificate.

Program Overview

Dissemination of information by experts experienced in clinical research and patient care is critical to address practicing dermatologists’ underlying educational needs, allowing them to confidently overcome demonstrated practice gaps.

In the field of cosmetic procedures, patient satisfaction, low risk-benefit ratio and patient’s quality of life are the primary success goals to be achieved by the physicians. Addressing patient management and therapeutic options for cosmetic surgery can provide education that is immediately applicable to clinical practice.

Target Audience

The target audience for this program is dermatologists, cosmetic surgeons (core specialties), and residents in these fields involved in the care of patients with dermatology needs.

Educational Method

Presentations will consist of lectures and panel discussions, featuring question-and-answer sessions, actual case presentations, as well as live injection demonstrations.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME).

2022 Faculty & Agenda

A list of invited faculty can be found here:

A complete agenda can be located here:


Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Evaluate the clinical and scientific differences between available botulinum toxin agents.
  • Discuss proper patient selection and safety concerns for neuro-modulators and injectable fillers.
  • Understand neuro-modulators and injectable fillers.
  • Evaluate complications from injectable fillers and discuss management and avoidance techniques.
  • Evaluate current and newly available fat removal therapies, devices and techniques.
  • Understand current and newly available scar treatment therapies.
  • Consider the various uses of dermatologic lasers in practice for medical and aesthetics applications to include skin and feminine rejuvenation, treatment of scars and hyperpigmentation.
  • Discuss newly available cosmeceuticals and their use in cosmetic dermatology.
  • Establish patient education efforts to improve expectations and understanding of complications in medical and cosmetic procedures, leading to improved satisfaction.
  • Discuss and analyze risk management in medical practice, problem solving and proper patient disclosure.
  • Identify new treatment strategies for aging patients and skin of color.
  • Discuss emerging treatments inclusive of pharmaceuticals, technologies and techniques.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented in accordance by Medical Education Resources (MER) and Cosmetic Surgery Forum (CSF).  MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME). the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity is supported by an educational grant and in-kind product donations from AbbVie, Galderma Laboratories and Merz North America, Inc. and a medical education grant from Bausch Health.

Designation Statement

Medical Education Resources designated this live CME activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Content Validation

In compliance with ACCME standards for commercial support and procedure for resolving conflicts of interest, this live activity will be peer reviewed for clinical content validity to ensure the activity’s materials are fair, balanced, and free of bias; the activity materials represent a standard of practice within the medical profession; and any studies cited in the materials upon which recommendations are based are scientifically objective and conform to research principles generally accepted by the scientific community.

Disclosure Policy

In accordance with disclosure policies and to conform with ACCME and US Food and Drug Administration guidelines, anyone in a position to affect the content of a CME activity is required to disclose to the activity participants: (1) the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices or providers of commercial services; and (2) identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.